No abstract available
MeSH terms
-
Adenomatous Polyps / prevention & control*
-
Cyclooxygenase 2 Inhibitors / adverse effects*
-
Data Interpretation, Statistical*
-
Follow-Up Studies
-
Humans
-
Lactones / adverse effects*
-
Proportional Hazards Models
-
Randomized Controlled Trials as Topic*
-
Risk
-
Sulfones / adverse effects*
-
Survival Analysis
-
Thrombosis / chemically induced
-
Time Factors
Substances
-
Cyclooxygenase 2 Inhibitors
-
Lactones
-
Sulfones
-
rofecoxib